QUANTIB® PROSTATE

Read prostate MRI at expert level supported by AI

Quantib® Prostate is here to help you manage the increase in prostate MRI workload and streamline the radiology workflow.
The FDA cleared and CE marked AI software provides a workflow for the detection of abnormalities on MRI prostate scans.

UTILIZE

Benefit from

One solution,
one workflow

No more switching between PACS, PSA density calculation feature and PI-RADS support; Quantib® Prostate offers one workflow including all essential prostate MRI reading features plus the generation of a standardized report.

AI-based support for
lesion assessment

Semi-automated combination of bi-parametric data supports ROI determination and enables prostate lesion evaluation. AI-driven prostate segmentation allows for easy and fast determination of volume.

Seamless integration into your workflow

The AI software can be installed onsite or on the cloud and is easily integrated with PACS. The output of the software is also compatible with certain ultrasound systems*.

INSIGHTS

Product Overview

Key features include

  • AI-driven prostate segmentation, volume measurements and integrated automatic PSA density calculation
  • Provides support for fast ROI segmentation of suspicious areas
  • Visual PI-RADS v.2.1 scoring support
  • Kinetic curve representation per ROI and of the full prostate gland
  • Export of prostate gland segmentation, ROIs and standardized report to PACS and compatible ultrasound systems*
  • A structured report including key images and visual representation of PI-RADS v.2.1 results

Quantib® Prostate is currently 510(k) cleared by the FDA for distribution in the US. This product complies with all applicable requirements of the European MDR (2017/745). Availability in EU countries upon request. Not commercially available in other countries.
TESTIMONIALS

Customer experience using Quantib® Prostate